AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
AtriCure (ATRC) Misses Q4 EPS by 14c, Revenues Miss; Offers 1Q & FY21 EPS/Revenue Guidance Below Consensus
February 23, 2021 4:07 PM ESTAtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.14 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.1 million.
Despite challenges posed in 2020 as a result of the pandemic, we made meaningful progress across our business with our strategic initiatives, said Michael Carrel, President and Chief Executive Officer... More
